Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation
- 14 January 2000
- journal article
- research article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 295 (2) , 163-168
- https://doi.org/10.1006/jmbi.1999.3368
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- HIV Entry and Its InhibitionPublished by Elsevier ,1998
- A Leucine Zipper-Like Sequence from the Cytoplasmic Tail of the HIV-1 Envelope Glycoprotein Binds and Perturbs Lipid BilayersBiochemistry, 1997
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.Proceedings of the National Academy of Sciences, 1994
- A Synthetic Peptide from HIV-1 gp41 Is a Potent Inhibitor of Virus-Mediated Cell—Cell FusionAIDS Research and Human Retroviruses, 1993
- Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.The Journal of Experimental Medicine, 1991
- A General Model for the Transmembrane Proteins of HIV and Other RetrovirusesAIDS Research and Human Retroviruses, 1989
- The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brainCell, 1986
- Binding of HTLV-III/LAV to T4 + T Cells by a Complex of the 110K Viral Protein and the T4 MoleculeScience, 1986
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984